Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from Genky DrugStores Co., Ltd. ( (JP:9267) ).
In December of the fiscal year ending June 2026, Genky DrugStores reported solid growth, with all-store net sales up 10.6% year on year and existing-store sales up 3.3%, driven mainly by a 2.7% increase in customer traffic and a modest rise in spending per customer. For the first half of the fiscal year, all-store sales rose 10.6% and existing-store sales 4.2%, as the company accelerated its expansion to 499 locations by year-end through 20 new store openings and ongoing refurbishment of larger outlets into standardized regular stores, underscoring a strategy of disciplined footprint growth and format standardization that supports steady same-store performance.
The most recent analyst rating on (JP:9267) stock is a Buy with a Yen6024.00 price target. To see the full list of analyst forecasts on Genky DrugStores Co., Ltd. stock, see the JP:9267 Stock Forecast page.
More about Genky DrugStores Co., Ltd.
Genky DrugStores Co., Ltd., listed on the TSE Prime, operates a chain of standardized 300-tsubo (about 999 m²) drugstores, focusing on daily necessities, pharmaceuticals and related retail products. The company continues to expand its network through a format of regular-sized stores while refurbishing larger outlets into standardized regular stores to enhance operational efficiency and store uniformity.
Average Trading Volume: 74,109
Technical Sentiment Signal: Buy
Current Market Cap: Yen154.5B
For detailed information about 9267 stock, go to TipRanks’ Stock Analysis page.